Quick Answer
Neurogene Inc. reported Shares Outstanding of 15.49 million shares for fiscal year 2025.
Neurogene Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 15.49M | +4.3% |
| 2024 | 14.85M | +15.8% |
| 2023 | 12.82M | — |
| 2022 | 0 | -100.0% |
| 2021 | 42.46M | +0.6% |
| 2020 | 42.20M | +11.1% |
| 2019 | 38.00M | +61.4% |
| 2018 | 23.54M | +0.3% |
| 2017 | 23.47M | +0.2% |
| 2016 | 23.42M | +36.1% |
| 2015 | 17.21M | +60.9% |
| 2014 | 10.70M | +3444.4% |
| 2013 | 301,745 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 14.78M | +13.6% | +3.5% |
| June 30, 2025 | 14.27M | +9.9% | -4.4% |
| March 31, 2025 | 14.93M | +16.1% | +0.5% |
| December 31, 2024 | 14.85M | +15.8% | +14.2% |
| September 30, 2024 | 13.01M | +47.8% | +0.2% |
| June 30, 2024 | 12.99M | -70.5% | +1.0% |
| March 31, 2024 | 12.86M | -70.0% | +0.3% |
| December 31, 2023 | 12.82M | +50.3% | +45.6% |
- Neurogene Inc. showed an increase of +4.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Neurogene Inc.’s shares outstanding has grown by 5033.4% (from 301.7 thousand shares to 15.49 million shares).
- The most recent figure is from Neurogene Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: